ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ESPR Esperion Therapeutics Inc

2.16
0.03 (1.41%)
Pre Market
Last Updated: 06:10:41
Delayed by 15 minutes

Period:

Draw Mode:

Volume 8,362
Bid Price 2.07
Ask Price 2.17
News -
Day High

Low
0.70

52 Week Range

High
3.40

Day Low
Company Name Stock Ticker Symbol Market Type
Esperion Therapeutics Inc ESPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 1.41% 2.16 06:10:41
Open Price Low Price High Price Close Price Prev Close
2.13
Trades Volume Avg Volume 52 Week Range
37 8,362 - 0.70 - 3.40
Last Trade Time Type Quantity Stock Price Currency
05:47:16 formt 100 $ 2.16 USD

Esperion Therapeutics (ESPR) Options Flow Summary

Overall Flow

Bearish

Net Premium

-47k

Calls / Puts

0.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Esperion Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
394.16M 185.05M - 116.33M -209.25M -1.13 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Esperion Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ESPR Message Board. Create One! See More Posts on ESPR Message Board See More Message Board Posts

Historical ESPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.862.161.711.985,707,3690.3016.13%
1 Month2.643.401.712.577,841,377-0.48-18.18%
3 Months2.163.401.712.516,376,7670.000.00%
6 Months0.8143.400.7062.255,998,0501.35165.36%
1 Year1.213.400.701.924,581,7470.9578.51%
3 Years27.5928.750.703.822,641,541-25.43-92.17%
5 Years41.8779.9890.708.751,826,076-39.71-94.84%

Esperion Therapeutics Description

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.

Your Recent History

Delayed Upgrade Clock